About Kurt Azarbarzin
Kurt Azarbarzin is an executive officer and director at Precision IO Group. He has been a TELA Bio board member since November 2018. He also serves on the board of Bright Uro, a medical technology business.
Azarbarzin led flexible-robot maker EndoQuest Robotics and served on its board from November 2020 to June 2024. He led robotic-surgery company Verb Surgical and served as a director from July 2019 to November 2020. He was CONMED's chief technology officer from 2016 to July 2019. He founded SurgiQuest, a minimally invasive surgery company, and led it from 2005 through June 2016. Earlier, he held research and development leadership roles at U.S. Surgical and Tyco Healthcare. He also chaired TELA Bio's board and served on a Yale biomedical technology center's executive board. He earned a bachelor's degree from the University of Bridgeport, then studied mechanical design at Bridgeport Engineering Institute and manufacturing engineering at Bradley University.
Experience
This experience comes from official bios, from Kurt Azarbarzin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kurt Azarbarzin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kurt Azarbarzin works with at each company, as listed on that company's latest Form D.
